These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32108853)

  • 1. Interaction of α-synuclein and Parkin in iron toxicity on SH-SY5Y cells: implications in the pathogenesis of Parkinson's disease.
    Ganguly U; Banerjee A; Chakrabarti SS; Kaur U; Sen O; Cappai R; Chakrabarti S
    Biochem J; 2020 Mar; 477(6):1109-1122. PubMed ID: 32108853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine Cytotoxicity on SH-SY5Y Cells: Involvement of α-Synuclein and Relevance in the Neurodegeneration of Sporadic Parkinson's Disease.
    Ganguly U; Ganguly A; Sen O; Ganguly G; Cappai R; Sahoo A; Chakrabarti S
    Neurotox Res; 2019 May; 35(4):898-907. PubMed ID: 30806984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein-induced mitochondrial dysfunction in isolated preparation and intact cells: implications in the pathogenesis of Parkinson's disease.
    Bir A; Sen O; Anand S; Khemka VK; Banerjee P; Cappai R; Sahoo A; Chakrabarti S
    J Neurochem; 2014 Dec; 131(6):868-77. PubMed ID: 25319443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Alpha-Synuclein Oligomers Induce Parkin S-Nitrosylation: Relevance to Sporadic Parkinson's Disease Etiopathology.
    Wilkaniec A; Lenkiewicz AM; Czapski GA; Jęśko HM; Hilgier W; Brodzik R; Gąssowska-Dobrowolska M; Culmsee C; Adamczyk A
    Mol Neurobiol; 2019 Jan; 56(1):125-140. PubMed ID: 29681024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roflupram attenuates α-synuclein-induced cytotoxicity and promotes the mitochondrial translocation of Parkin in SH-SY5Y cells overexpressing A53T mutant α-synuclein.
    Zhong J; Li M; Xu J; Dong W; Qin Y; Qiu S; Li X; Wang H
    Toxicol Appl Pharmacol; 2022 Feb; 436():115859. PubMed ID: 34990728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parkin interacting substrate zinc finger protein 746 is a pathological mediator in Parkinson's disease.
    Brahmachari S; Lee S; Kim S; Yuan C; Karuppagounder SS; Ge P; Shi R; Kim EJ; Liu A; Kim D; Quintin S; Jiang H; Kumar M; Yun SP; Kam TI; Mao X; Lee Y; Swing DA; Tessarollo L; Ko HS; Dawson VL; Dawson TM
    Brain; 2019 Aug; 142(8):2380-2401. PubMed ID: 31237944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of Parkinson's disease: a common pathway between alpha-synuclein and parkin and the mechanism of Lewy bodies formation].
    Hattori N; Machida Y; Noda K
    Rinsho Shinkeigaku; 2005 Nov; 45(11):905-7. PubMed ID: 16447759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peiminine Reduces ARTS-Mediated Degradation of XIAP by Modulating the PINK1/Parkin Pathway to Ameliorate 6-Hydroxydopamine Toxicity and α-Synuclein Accumulation in Parkinson's Disease Models In Vivo and In Vitro.
    Hsu YL; Hung HS; Tsai CW; Liu SP; Chiang YT; Kuo YH; Shyu WC; Lin SZ; Fu RH
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of Parkin at serine 131 by p38 MAPK promotes mitochondrial dysfunction and neuronal death in mutant A53T α-synuclein model of Parkinson's disease.
    Chen J; Ren Y; Gui C; Zhao M; Wu X; Mao K; Li W; Zou F
    Cell Death Dis; 2018 Jun; 9(6):700. PubMed ID: 29899409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells.
    Chen Y; Lian YJ; Ma YQ; Wu CJ; Zheng YK; Xie NC
    Neurotoxicology; 2018 Sep; 68():212-221. PubMed ID: 29217406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein.
    Li XZ; Zhang SN; Wang KX; Liu HY; Yang ZM; Liu SM; Lu F
    Phytomedicine; 2014 Apr; 21(5):704-11. PubMed ID: 24252343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
    Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
    Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein knockdown attenuates MPP+ induced mitochondrial dysfunction of SH-SY5Y cells.
    Wu F; Poon WS; Lu G; Wang A; Meng H; Feng L; Li Z; Liu S
    Brain Res; 2009 Oct; 1292():173-9. PubMed ID: 19646423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson's disease.
    Yasuda T; Mochizuki H
    Apoptosis; 2010 Nov; 15(11):1312-21. PubMed ID: 20221696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of Autophagy by Vasicinone Protects Neural Cells from Mitochondrial Dysfunction and Attenuates Paraquat-Mediated Parkinson's Disease Associated α-Synuclein Levels.
    Huang CY; Sivalingam K; Shibu MA; Liao PH; Ho TJ; Kuo WW; Chen RJ; Day CH; Viswanadha VP; Ju DT
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32517337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination increases parkin activity to promote autophagic α-synuclein clearance.
    Lonskaya I; Desforges NM; Hebron ML; Moussa CE
    PLoS One; 2013; 8(12):e83914. PubMed ID: 24386307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α-Synuclein Regulates Iron Homeostasis via Preventing Parkin-Mediated DMT1 Ubiquitylation in Parkinson's Disease Models.
    Bi M; Du X; Jiao Q; Liu Z; Jiang H
    ACS Chem Neurosci; 2020 Jun; 11(11):1682-1691. PubMed ID: 32379419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drp-1 dependent mitochondrial fragmentation and protective autophagy in dopaminergic SH-SY5Y cells overexpressing alpha-synuclein.
    Martinez JH; Alaimo A; Gorojod RM; Porte Alcon S; Fuentes F; Coluccio Leskow F; Kotler ML
    Mol Cell Neurosci; 2018 Apr; 88():107-117. PubMed ID: 29414102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inclusion body formation and neurodegeneration are parkin independent in a mouse model of alpha-synucleinopathy.
    von Coelln R; Thomas B; Andrabi SA; Lim KL; Savitt JM; Saffary R; Stirling W; Bruno K; Hess EJ; Lee MK; Dawson VL; Dawson TM
    J Neurosci; 2006 Apr; 26(14):3685-96. PubMed ID: 16597723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.